Signal Peptide Database - Viruses

 Entry Details
ID   4841
Source Database   UniProtKB/Swiss-Prot
UniProtKB/Swiss-Prot Accession Number   P25194    (Created: 1992-05-01 Updated: 2008-11-25)
UniProtKB/Swiss-Prot Entry Name   SPIKE_CVBV
Protein Name   Spike glycoprotein
Gene   S
Organism Scientific   Bovine coronavirus (strain vaccine)
Organism Common   BCoV
Lineage   Viruses
  ssRNA positive-strand viruses, no DNA stage
    Nidovirales
      Coronaviridae
        Coronavirus
          Coronavirus group 2
            Coronavirus group 2a
Protein Length [aa]   1363
Protein Mass [Da]   150843
Features  
TypeDescriptionStatusStartEnd
signal peptide      potential   1   17
chain   Spike glycoprotein      18   1363
chain   Spike protein S1   potential   18   768
chain   Spike protein S2   potential   769   1363
transmembrane region      potential   1312   1328
topological domain   Extracellular   potential   18   1311
topological domain   Cytoplasmic   potential   1329   1363
glycosylation site   N-linked (GlcNAc...)   potential   59   59
glycosylation site   N-linked (GlcNAc...)   potential   133   133
glycosylation site   N-linked (GlcNAc...)   potential   198   198
glycosylation site   N-linked (GlcNAc...)   potential   359   359
glycosylation site   N-linked (GlcNAc...)   potential   437   437
glycosylation site   N-linked (GlcNAc...)   potential   649   649
glycosylation site   N-linked (GlcNAc...)   potential   676   676
glycosylation site   N-linked (GlcNAc...)   potential   696   696
glycosylation site   N-linked (GlcNAc...)   potential   714   714
glycosylation site   N-linked (GlcNAc...)   potential   739   739
glycosylation site   N-linked (GlcNAc...)   potential   788   788
glycosylation site   N-linked (GlcNAc...)   potential   937   937
glycosylation site   N-linked (GlcNAc...)   potential   1194   1194
glycosylation site   N-linked (GlcNAc...)   potential   1224   1224
glycosylation site   N-linked (GlcNAc...)   potential   1234   1234
glycosylation site   N-linked (GlcNAc...)   potential   1253   1253
glycosylation site   N-linked (GlcNAc...)   potential   1267   1267
glycosylation site   N-linked (GlcNAc...)   potential   1288   1288
site   Cleavage; by host   potential   768   769
compositionally biased region   Cys-rich      1329   1346
coiled-coil region      potential   1043   1087
coiled-coil region      potential   1269   1297
SP Length   17
 ----+----1----+----2----+----3----+----4----+----5
Signal Peptide MFLILLISLPMAFAVIG
Sequence MFLILLISLPMAFAVIGDLKCTTVSINDVDTGAPSISTDTVDVTNGLGTY
YVLDRVYL
NTTLLLNGYYPTSGSTYRNMALKGTLLLSRLWFKPPFLSDFI
NGIFAKVKNTKVIKKGVMYSEFPAITIGSTFV
NTSYSVVVQPHTTNLDNK
LQGLLEISVCQYTMCEYPHTICHPNLGNQRVELWHWDTGVVSCLYKR
NFT
YDVNADYLYFHFYQEGGTFYAYFTDTGVVTKFLFNVYLGTVLSHYYVLPL
TCYSAMTLEYWVTPLTSKQYLLAFNQDGVIFNAVDCKSDFMSEIKCKTLS
IAPSTGVYELNGYTVQPIADVYRRIPNLPDCNIEAWLNDKSVPSPLNWER
KTFSNCNF
NMSSLMSFIQADSFTCNNIEAAKIYGMCFSSITIDKFAIPNG
RKVDLQLGNLGYLQSFNYRIDTTAASCQLYYNLPAA
NVSVSRFNPSTWNR
RFGFTEQSVFKPQPVGVFTHHDVVYAQHCFKAPTNFCPCKLDGSLCVGNG
PGIDAGYKNSGIGTCPAGTNYLTCHNAAQCDCLCTPDPITSKSTGPYKCP
QTKYLVGIGEHCSGLAIKSDYCGGNPCTCQPQAFLGWSVDSCLQGDRCNI
FANFILHDVNSGTTCSTDLQKSNTDIILGVCVNYDLYGITGQGIFVEV
NA
TYYNSWQNLLYDSNGNLYGFRDYLT
NRTFMIRSCYSGRVSAAFHANSSEP
ALLFRNIKCNYVF
NNTLSRQLQPINYFDSYLGCVVNADNSTSSVVQTCDL
TVGSGYCVDYSTKRRSR
RAITTGYRFTNFEPFTVNSVNDSLEPVGGLYEI
QIPSEFTIGNMEEFIQTSSPKVTIDCSAFVCGDYAACKSQLVEYGSFCDN
INAILTEVNELLDTTQLQVANSLMNGVTLSTKLKDGVNFNVDDINFSPVL
GCLGSDCNKVSSRSAIEDLLFSKVKLSDVGFVEAYN
NCTGGAEIRDLICV
QSYNGIKVLPPLLSVNQISGYTLAATSASLFPPWSAAAGVPFYLNVQYRI
NGIGVTMDVLSQNQKLIANAFNNALDAIQEGFDATNSALVKI
QAVVNANA
EALNNLLQQLSNRFGAISSSLQEILSRLDALEAQAQI
DRLINGRLTALNA
YVSQQLSDSTLVKFSAAQAMEKVNECVKSQSSRINFCGNGNHIISLVQNA
PYGLYFIHFSYVPTKYVTAKVSPGLCIAGDRGIAPKSGYFVNV
NNTWMFT
GSGYYYPEPITGNNVVVMSTCAV
NYTKAPDVMLNISTPNLHDFKEELDQW
FK
NQTSVAPDLSLDYINVTFLDLQDEMNRLQEAIKVLNQSYINLKDIGTY
EYYVKWPWYVW
LLIGFAGVAMLVLLFFICCCTGCGTSCFKICGGCCDDYT
GHQELVIKTSHDD
Original MFLILLISLPMAFAVIGDLKCTTVSINDVDTGAPSISTDTVDVTNGLGTY
YVLDRVYLNTTLLLNGYYPTSGSTYRNMALKGTLLLSRLWFKPPFLSDFI
NGIFAKVKNTKVIKKGVMYSEFPAITIGSTFVNTSYSVVVQPHTTNLDNK
LQGLLEISVCQYTMCEYPHTICHPNLGNQRVELWHWDTGVVSCLYKRNFT
YDVNADYLYFHFYQEGGTFYAYFTDTGVVTKFLFNVYLGTVLSHYYVLPL
TCYSAMTLEYWVTPLTSKQYLLAFNQDGVIFNAVDCKSDFMSEIKCKTLS
IAPSTGVYELNGYTVQPIADVYRRIPNLPDCNIEAWLNDKSVPSPLNWER
KTFSNCNFNMSSLMSFIQADSFTCNNIEAAKIYGMCFSSITIDKFAIPNG
RKVDLQLGNLGYLQSFNYRIDTTAASCQLYYNLPAANVSVSRFNPSTWNR
RFGFTEQSVFKPQPVGVFTHHDVVYAQHCFKAPTNFCPCKLDGSLCVGNG
PGIDAGYKNSGIGTCPAGTNYLTCHNAAQCDCLCTPDPITSKSTGPYKCP
QTKYLVGIGEHCSGLAIKSDYCGGNPCTCQPQAFLGWSVDSCLQGDRCNI
FANFILHDVNSGTTCSTDLQKSNTDIILGVCVNYDLYGITGQGIFVEVNA
TYYNSWQNLLYDSNGNLYGFRDYLTNRTFMIRSCYSGRVSAAFHANSSEP
ALLFRNIKCNYVFNNTLSRQLQPINYFDSYLGCVVNADNSTSSVVQTCDL
TVGSGYCVDYSTKRRSRRAITTGYRFTNFEPFTVNSVNDSLEPVGGLYEI
QIPSEFTIGNMEEFIQTSSPKVTIDCSAFVCGDYAACKSQLVEYGSFCDN
INAILTEVNELLDTTQLQVANSLMNGVTLSTKLKDGVNFNVDDINFSPVL
GCLGSDCNKVSSRSAIEDLLFSKVKLSDVGFVEAYNNCTGGAEIRDLICV
QSYNGIKVLPPLLSVNQISGYTLAATSASLFPPWSAAAGVPFYLNVQYRI
NGIGVTMDVLSQNQKLIANAFNNALDAIQEGFDATNSALVKIQAVVNANA
EALNNLLQQLSNRFGAISSSLQEILSRLDALEAQAQIDRLINGRLTALNA
YVSQQLSDSTLVKFSAAQAMEKVNECVKSQSSRINFCGNGNHIISLVQNA
PYGLYFIHFSYVPTKYVTAKVSPGLCIAGDRGIAPKSGYFVNVNNTWMFT
GSGYYYPEPITGNNVVVMSTCAVNYTKAPDVMLNISTPNLHDFKEELDQW
FKNQTSVAPDLSLDYINVTFLDLQDEMNRLQEAIKVLNQSYINLKDIGTY
EYYVKWPWYVWLLIGFAGVAMLVLLFFICCCTGCGTSCFKICGGCCDDYT
GHQELVIKTSHDD
 ----+----1----+----2----+----3----+----4----+----5
Hydropathies  
 

© 2007-2017 Dr. Katja Kapp, Kassel & thpr.net e. K., Dresden, Germany, last update 2010-06-11